| Phage cocktails and the future of phage therapy BK Chan, ST Abedon, C Loc-Carrillo Future microbiology 8 (6), 769-783, 2013 | 1076 | 2013 |
| Phage therapy: a renewed approach to combat antibiotic-resistant bacteria KE Kortright, BK Chan, JL Koff, PE Turner Cell host & microbe 25 (2), 219-232, 2019 | 1074 | 2019 |
| Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa BK Chan, M Sistrom, JE Wertz, KE Kortright, D Narayan, PE Turner Scientific reports 6 (1), 26717, 2016 | 712 | 2016 |
| Phage treatment of an aortic graft infected with Pseudomonas aeruginosa BK Chan, PE Turner, S Kim, HR Mojibian, JA Elefteriades, D Narayan Evolution, medicine, and public health 2018 (1), 60-66, 2018 | 528 | 2018 |
| Considerations for the use of phage therapy in clinical practice GA Suh, TP Lodise, PD Tamma, JM Knisely, J Alexander, S Aslam, ... Antimicrobial agents and chemotherapy 66 (3), e02071-21, 2022 | 284 | 2022 |
| Phage therapy pharmacology: phage cocktails BK Chan, ST Abedon Advances in applied microbiology 78, 1-23, 2012 | 259 | 2012 |
| Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance AR Burmeister, A Fortier, C Roush, AJ Lessing, RG Bender, R Barahman, ... Proceedings of the National Academy of Sciences 117 (21), 11207-11216, 2020 | 250 | 2020 |
| Bacteriophages and their enzymes in biofilm control B K. Chan, S T. Abedon Current pharmaceutical design 21 (1), 85-99, 2015 | 235 | 2015 |
| Current state of compassionate phage therapy S McCallin, JC Sacher, J Zheng, BK Chan Viruses 11 (4), 343, 2019 | 215 | 2019 |
| High-throughput discovery of phage receptors using transposon insertion sequencing of bacteria KE Kortright, BK Chan, PE Turner Proceedings of the National Academy of Sciences 117 (31), 18670-18679, 2020 | 116 | 2020 |
| Phage steering of antibiotic-resistance evolution in the bacterial pathogen, Pseudomonas aeruginosa J Gurney, L Pradier, JS Griffin, C Gougat-Barbera, BK Chan, PE Turner, ... Evolution, medicine, and public health 2020 (1), 148-157, 2020 | 87 | 2020 |
| The developing world urgently needs phages to combat pathogenic bacteria TE Nagel, BK Chan, D De Vos, A El-Shibiny, EK Kang'Ethe, A Makumi, ... Frontiers in Microbiology 7, 882, 2016 | 87 | 2016 |
| Quantitative models of phage-antibiotic combination therapy RA Rodriguez-Gonzalez, CY Leung, BK Chan, PE Turner, JS Weitz MSystems 5 (1), 10.1128/msystems. 00756-19, 2020 | 84 | 2020 |
| Bacteriophage therapy for infections in CF BK Chan, G Stanley, M Modak, JL Koff, PE Turner Pediatric pulmonology 56, S4-S9, 2021 | 62 | 2021 |
| Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa T Köhler, A Luscher, L Falconnet, G Resch, R McBride, QA Mai, ... Nature communications 14 (1), 3629, 2023 | 41 | 2023 |
| Successful Treatment of a Recalcitrant Staphylococcus epidermidis Prosthetic Knee Infection with Intraoperative Bacteriophage Therapy JB Doub, VY Ng, E Wilson, L Corsini, BK Chan Pharmaceuticals 14 (3), 231, 2021 | 40 | 2021 |
| Experience using adjuvant bacteriophage therapy for the treatment of 10 recalcitrant periprosthetic joint infections: a case series JB Doub, AJ Johnson, S Nandi, V Ng, T Manson, M Lee, B Chan Clinical Infectious Diseases 76 (3), e1463-e1466, 2023 | 31 | 2023 |
| Hydrogen peroxide vapor decontamination of N95 respirators for reuse PA Kenney, BK Chan, KE Kortright, M Cintron, M Russi, J Epright, L Lee, ... Infection Control & Hospital Epidemiology 43 (1), 45-47, 2022 | 31 | 2022 |
| Evolution of bacterial cross-resistance to lytic phages and albicidin antibiotic KE Kortright, S Doss-Gollin, BK Chan, PE Turner Frontiers in microbiology 12, 658374, 2021 | 31 | 2021 |
| Arms race and fluctuating selection dynamics in Pseudomonas aeruginosa bacteria coevolving with phage OMKO1 KE Kortright, BK Chan, BR Evans, PE Turner Journal of Evolutionary Biology 35 (11), 1475-1487, 2022 | 26 | 2022 |
